These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33994282)

  • 21. Nonroutine Use of Intra-Aortic Balloon Pump in Cardiogenic Shock Complicating Myocardial Infarction With Successful and Unsuccessful Primary Percutaneous Coronary Intervention.
    Hawranek M; Gierlotka M; Pres D; Zembala M; Gąsior M
    JACC Cardiovasc Interv; 2018 Sep; 11(18):1885-1893. PubMed ID: 30236362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial.
    Thiele H; Zeymer U; Neumann FJ; Ferenc M; Olbrich HG; Hausleiter J; de Waha A; Richardt G; Hennersdorf M; Empen K; Fuernau G; Desch S; Eitel I; Hambrecht R; Lauer B; Böhm M; Ebelt H; Schneider S; Werdan K; Schuler G;
    Lancet; 2013 Nov; 382(9905):1638-45. PubMed ID: 24011548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Preference, Effect, and Prognosis of Intra-Aortic Balloon Counterpulsation in Acute Myocardial Infarction Complicated by Cardiogenic Shock Patients: A Retrospective Cohort Study.
    Wang W; Yang F; Lin X; Zhong Q; Li Z; Chen X; Wang J; He K
    Biomed Res Int; 2021; 2021():6656926. PubMed ID: 33542922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early application of an intra-aortic balloon pump in patients with ST-segment elevation acute myocardial infarction scheduled for elective percutaneous coronary intervention.
    Li Z; Dong P; Liu X; Yang X; Wang K; Li Z; Zhao Y; Jin G; Li Z; Li C
    J Int Med Res; 2013 Jun; 41(3):754-61. PubMed ID: 23613498
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial.
    Prondzinsky R; Unverzagt S; Russ M; Lemm H; Swyter M; Wegener N; Buerke U; Raaz U; Ebelt H; Schlitt A; Heinroth K; Haerting J; Werdan K; Buerke M
    Shock; 2012 Apr; 37(4):378-84. PubMed ID: 22266974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of intra-aortic balloon pump on in-hospital outcomes and 1-year mortality in patients with acute myocardial infarction complicated by cardiogenic shock.
    Fang D; Yu D; Xu J; Ma W; Zhong Y; Chen H
    BMC Cardiovasc Disord; 2023 Aug; 23(1):425. PubMed ID: 37644466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benefits of Intraaortic Balloon Support for Myocardial Infarction Patients in Severe Cardiogenic Shock Undergoing Coronary Revascularization.
    Mao CT; Wang JL; Chen DY; Tsai ML; Lin YS; Cherng WJ; Wang CH; Wen MS; Hsieh IC; Hung MJ; Chen CC; Chen TH
    PLoS One; 2016; 11(8):e0160070. PubMed ID: 27483439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-Aortic Balloon Pump Counterpulsation during Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction and Cardiogenic Shock: Insights from the British Columbia Cardiac Registry.
    Iqbal MB; Robinson SD; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Della Siega A; Nadra IJ;
    PLoS One; 2016; 11(2):e0148931. PubMed ID: 26870950
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of intra-aortic balloon counter-pulsation on in-hospital mortality in patients presenting with anterior ST-elevation myocardial infarction without cardiogenic shock.
    Mahmoudi M; Hauville C; Gaglia MA; Sardi G; Torguson R; Xue Z; Satler LF; Suddath WO; Pichard AD; Waksman R
    Cardiovasc Revasc Med; 2012; 13(6):328-30. PubMed ID: 23062956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Gender difference in efficacy of intra-aortic balloon pump in acute myocardial infarction patients complicating with cardiogenic shock].
    Guo C; Teng HB; Zhang J; Li J; Xu HB; Wang XY; Yuan JS; Yang WX; Hu FH; Wu Y; Qiao SB
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Aug; 48(8):675-681. PubMed ID: 32847324
    [No Abstract]   [Full Text] [Related]  

  • 31. Correlates for mortality in patients presented with acute myocardial infarct complicated by cardiogenic shock.
    Minha S; Barbash IM; Dvir D; Ben-Dor I; Loh JP; Pendyala LK; Satler LF; Pichard AD; Torguson R; Waksman R
    Cardiovasc Revasc Med; 2014 Jan; 15(1):13-7. PubMed ID: 24444472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Status of intra-aortic balloon pump application and related factors in Chinese patients with acute myocardial infarction].
    Wu NQ; Gao Z; Zheng Y; Li W; Li JN; Xu HY; Cheng XS; Wu Y; Wang Y; Wang ZJ; Yang JG; Yang YJ;
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Jan; 46(1):26-31. PubMed ID: 29374934
    [No Abstract]   [Full Text] [Related]  

  • 33. Impact of intra-aortic balloon pump on short-term clinical outcomes in ST-elevation myocardial infarction complicated by cardiogenic shock: A "real life" single center experience.
    de la Espriella-Juan R; Valls-Serral A; Trejo-Velasco B; Berenguer-Jofresa A; Fabregat-Andrés Ó; Perdomo-Londoño D; Albiach-Montañana C; Vilar-Herrero JV; Sanmiguel-Cervera D; Rumiz-Gonzalez E; Morell-Cabedo S
    Med Intensiva; 2017 Mar; 41(2):86-93. PubMed ID: 27650459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Volume-Outcome Relationships for Intra-Aortic Balloon Pump in Acute Myocardial Infarction.
    Saito Y; Tateishi K; Kanda M; Shiko Y; Kawasaki Y; Kobayashi Y; Inoue T
    Circ J; 2024 Jul; 88(8):1286-1292. PubMed ID: 38925938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic intra-aortic balloon counterpulsation before surgical myocardial revascularization in patients with acute myocardial infarction.
    Grieshaber P; Schneider T; Oster L; Orhan C; Roth P; Niemann B; Böning A
    Perfusion; 2018 Jul; 33(5):390-400. PubMed ID: 29457560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Impact and clinical outcome of intra-aortic balloon pump use during percutaneous coronary intervention].
    Xu JJ; Gao Z; Song Y; Ma YL; Tang XF; Yao Y; He C; Wang HH; Yang YJ; Gao RL; Qiao SB; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jul; 45(7):572-578. PubMed ID: 28738485
    [No Abstract]   [Full Text] [Related]  

  • 37. Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial.
    Mehta SR; Steg PG; Granger CB; Bassand JP; Faxon DP; Weitz JI; Afzal R; Rush B; Peters RJ; Natarajan MK; Velianou JL; Goodhart DM; Labinaz M; Tanguay JF; Fox KA; Yusuf S;
    Circulation; 2005 Mar; 111(11):1390-7. PubMed ID: 15781750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock.
    Unverzagt S; Machemer MT; Solms A; Thiele H; Burkhoff D; Seyfarth M; de Waha A; Ohman EM; Buerke M; Haerting J; Werdan K; Prondzinsky R
    Cochrane Database Syst Rev; 2011 Jul; (7):CD007398. PubMed ID: 21735410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial.
    Mehta SR; Granger CB; Eikelboom JW; Bassand JP; Wallentin L; Faxon DP; Peters RJ; Budaj A; Afzal R; Chrolavicius S; Fox KA; Yusuf S
    J Am Coll Cardiol; 2007 Oct; 50(18):1742-51. PubMed ID: 17964037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indications, results of therapy and factors which influence survival in patients treated with intra-aortic balloon counterpulsation.
    Olasińska-Wiśniewska A; Mularek-Kubzdela T; Grajek S; Breborowicz P; Seniuk W; Podzerek T
    Kardiol Pol; 2008 Sep; 66(9):950-5; discussion 956-7. PubMed ID: 18924022
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.